- Easy Tracking In The Watchlist
Evaluation of Tekla Life Sciences Investors stock downgraded after the last trading session
(Updated on Jul 31, 2026)
The Tekla Life Sciences Investors stock price fell by -1.75% on the last day (Friday, 31st Jul 2026) from $19.44 to $19.10. During the last trading day the stock fluctuated 2.89% from a day low at $19.00 to a day high of $19.55. The price has fallen in 6 of the last 10 days and is down by -3.24% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -74 thousand shares and in total, 146 thousand shares were bought and sold for approximately $2.79 million.
The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 15.42% during the next 3 months and, with a 90% probability hold a price between $20.97 and $24.92 at the end of this 3-month period.
HQL Signals & Forecast
There are few to no technical positive signals at the moment. The Tekla Life Sciences Investors stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $19.33 and $19.26. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -8.31%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Tekla Life Sciences Investors stock
On the downside, the stock finds support just below today's level from accumulated volume at $17.96 and $17.86. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Tekla Life Sciences Investors finds support just below today's level at $17.96. If this is broken, then the next support from accumulated volume will be at $17.86 and $17.67.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.550 (2.89%) between high and low. For the last week, the stock has had daily average volatility of 2.17%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (HQL) For The Upcoming Trading Day Of Monday 3rd
For the upcoming trading day on Monday, 3rd we expect Tekla Life Sciences Investors to open at $19.22, and during the day (based on 14 day Average True Range), to move between $18.88 and $19.32, which gives a possible trading interval of +/-$0.443 (+/-2.34%) up or down from last closing price. If Tekla Life Sciences Investors takes out the full calculated possible swing range there will be an estimated 2.34% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $19.25 (0.79%) than the support at $17.96 (5.97%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Tekla Life Sciences Investors stock A Buy?
The Tekla Life Sciences Investors stock holds several negative signals and despite the positive trend, we believe Tekla Life Sciences Investors will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.
Current score:
-2.420
Sell Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on August 3, 2026 - $19.22 ( 0.611%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
HQL Performance
Trading levels for HQL
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 19.77 | 3.49% |
| R2 | 19.56 | 2.39% |
| R1 | 19.43 | 1.71% |
| Price | 19.10 | |
| S1 | 19.01 | -0.489% |
| S2 | 18.88 | -1.17% |
| S3 | 18.67 | -2.27% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 20.15 | 5.50% |
| R2 | 19.34 | 1.26% |
| R1 | 19.25 | 0.785% |
| Price | 19.10 | |
| S1 | 17.96 | -5.97% |
| S2 | 17.86 | -6.49% |
| S3 | 17.67 | -7.49% |
HQL Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | May 11, 2026 | May 21, 2026 | Jun 30, 2026 | $0.560 | 3.08% |
| 2 | Feb 20, 2026 | Feb 20, 2026 | Mar 31, 2026 | $0.560 | 3.34% |
| 3 | Nov 21, 2025 | Nov 21, 2025 | Jan 12, 2026 | $0.500 | 2.90% |
| 4 | Aug 22, 2025 | Aug 22, 2025 | Sep 30, 2025 | $0.420 | 3.03% |
| 5 | May 22, 2025 | May 22, 2025 | Jun 30, 2025 | $0.430 | 3.38% |
FAQ
Click here for our free guide on how to buy Tekla Life Sciences Investors Stock.
Buy HQL